Table 5.

Summary of GSH, iron, NRF2, and ROS associated lncRNAs in cancer.

Control point	Name	Associated cancer type	Target	Influence to control point	Model of evidence	Reference
GSH	Linc01419	Esophageal squamous cell carcinoma	GST	Up	Clinical samples	144
	Neat1	Hepatocellular carcinoma	GST	Up	Cell culture	143
	H19	Ovarian cancer	GCLC, GCLM, GST	Up/Down	Cell culture, animal models	145
	Xist	Colorectal cancer	GST	Down	Cell culture, animal models	48
	Ror	Breast cancer	GST	Down	Cell culture, animal models	142
Iron	Pvt1	Hepatocellular carcinoma	miR-150/HIG2	Up	Cell culture, animal models	146
	H19	Myeloid leukemia	miR-675	Inhibited by iron	Cell culture	147
NRF2	Aatbc	Bladder cancer	NRF2	Down	Cell culture, animal models	148
	Kral	Hepatocellular carcinoma	KEAP1	Down	Cell culture	91
	Malat1	Multiple myeloma	KEAP1	Down	Cell culture, animal models	149
	H19	Ovarian cancer	NRF2	Down	Cell culture, animal models	145
	Scal1	Lung cancer	–	Induced by NRF2	Cell culture	92
	Loc344887	Gallbladder cancer	–	Induced by NRF2	Cell culture	150
ROS	Meg3	Lung cancer	P53	Up	Cell culture	154
	Uca1	Bladder cancer	miR-16	Down	Cell culture	151
	Gas5	Melanoma	G6PD	Down	Cell culture	153
	H19	Hepatocellular carcinoma	MAPK/ERK signaling pathway	Down	Cell culture	152
	Miat	Neuroblastoma, glioblastoma	MAPK7, FUT8, and MCL1	Unknown	Cell culture	289–295